AnaptysBio, Inc. (ANAB) Surpasses Q3 Earnings and Revenue Estimates

AnaptysBio, Inc. (ANAB) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of a loss of$ 1.06 per share. This compares to a loss of $1.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +149.06%. A quarter ago, it was expected that this company would post a loss of$ 1.5 per share when it actually produced a loss of $1.34, delivering a surprise of +10.67%.Over the last four quarters, the c ...